CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growth in the biopharmaceutical industry
4.1.2. Increasing pressure to lower the cost of manufacturing
4.1.3. Growth in the biopharmaceutical industry
4.1.4. Growing R&D spending
4.2. Market Restraints & Challenges
4.2.1. The high cost of advanced technologies
4.2.2. Lack of adequate infrastructural facilities
4.3. Market Opportunities
4.3.1. Adoption of quality by design(QBD) principles
CHAPTER 5. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET – BY MOLECULE TYPE
5.1. Introduction
5.2. Monoclonal antibodies
5.3. Other molecules
CHAPTER 6. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET – BY PRODUCT & SERVICE
6.1. Introduction
6.2. Consumables
6.2.1. Miniature prepacked columns
6.2.2. Microtiter plates
6.2.3. Miniaturized disposable bioreactor
6.2.4. Micropipettes and pipette tips
6.2.5. Other consumables
6.3. Instruments
6.3.1. Automated integrated workstation
6.3.2. The automated miniature bioreactor system
6.4. Services
6.5. Software
CHAPTER 7. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET – BY TECHNOLOGY
7.1. Introduction services
7.2. Chromatography
7.2.1. Affinity chromatography
7.2.2. Multimodal chromatography
7.2.3. Ion-exchange chromatography
7.2.4. Other chromatography
7.3. Ultraviolet-visible spectroscopy
7.4. Other technologies
CHAPTER 8. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET - BY END USER
8.1. Introduction
8.2. Biopharmaceutical
8.3. Contract research organisation
8.4. Academic research institutes
CHAPTER 9. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET - COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.2. Aurora Biomed Inc.
10.3. Bio-Rad Laboratories, Inc.
10.4. Danaher Corporation
10.5. Hamilton Company
10.6. Merck Millipore Corporation.
10.7. Perkin Elmer, Inc.
10.8. Tecan Group Ltd.
10.9. Thermo Fisher Scientific, Inc.
10.10. GE Healthcare
10.11. Eppendorf
10.12. Apollo Munich Health Insurance.
10.13. Axxam S.P.A.
10.14. UnitedHealth Group Inc.
CHAPTER 11. GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT
MARKET – COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
